Real-life effectiveness evaluation of asthma treatment in Korea

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/27681
• EU PAS number:
  EUPAS12279
• Study ID:
  27681
• Official title and acronym:
  Real-life effectiveness evaluation of asthma treatment in Korea
• DARWIN EU® study:
  No
• Study countries:
  Korea, Republic of
• Study description:
  Evaluating inhaler device ‘switch success’ and the real-life effectiveness in the Ajou University Hospital Database in Korea
• Study status:
  Finalised

Research institutions and networks

Institutions

Observational & Pragmatic Research Institute Pte (OPRI)

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 03/02/2016

Actual: 29/02/2016

Study start date

Planned: 01/04/2016

Actual: 19/08/2016

Data analysis start date

Planned: 29/04/2016

Actual: 01/09/2016

Date of interim report, if expected

Planned: 30/09/2016

Actual: 23/09/2016

Date of final study report

Planned: 01/12/2016

Actual: 27/06/2017

Sources of funding

Other

Pharmaceutical company and other private sector 

More details on funding

Mundipharma, RIRL

Study protocol

Initial protocol

201602013_TransfformAjouv1

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable